BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.
Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using...
Headed up by Penny Kyle
Ex-Standard life manager Angela Burns
Latest news and analysis
Talking Strategies: The number of companies in Asia with higher payout ratios have grown since the mid-1990s, but some investors remain wary of searching for income in Asia and Japan. In this video, Jupiter's Jason Pidcock and Dan Carter explain why this...